fenofibrate has been researched along with Bone Loss, Osteoclastic in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bezafibrate treatment of mature osteoclast resulted in 50% inhibition (at 10(-8) M and 10(-7) M) of resorption, yet fenofibrate had no significant effect." | 1.34 | PPAR agonists modulate human osteoclast formation and activity in vitro. ( Buckley, KA; Chan, BY; Dillon, JP; Fraser, WD; Gallagher, JA; Gartland, A; Wilson, PJ, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samadfam, R | 1 |
| Awori, M | 1 |
| Bénardeau, A | 1 |
| Bauss, F | 1 |
| Sebokova, E | 1 |
| Wright, M | 1 |
| Smith, SY | 1 |
| Chan, BY | 1 |
| Gartland, A | 1 |
| Wilson, PJ | 1 |
| Buckley, KA | 1 |
| Dillon, JP | 1 |
| Fraser, WD | 1 |
| Gallagher, JA | 1 |
2 other studies available for fenofibrate and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats.
Topics: Adiposity; Animals; Biomarkers; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone | 2012 |
PPAR agonists modulate human osteoclast formation and activity in vitro.
Topics: Acetates; Apoptosis; Bezafibrate; Bone Resorption; Butyrates; Cells, Cultured; Fenofibrate; Humans; | 2007 |